Please login to the form below

Not currently logged in
Email:
Password:

Ponesimod

This page shows the latest Ponesimod news and features for those working in and with pharma, biotech and healthcare.

J&J aims for US approval of MS drug ponesimod

J&J aims for US approval of MS drug ponesimod

J&J acquired the S1P receptor modulator as part its $30bn takeover of Actelion, with the FDA application based on the head-to-head phase 3 OPTIMUM study comparing ponesimod to ... Data from that trial showed that treatment with ponesimod was associated

Latest news

  • J&J’s ponesimiod tops Aubagio in head-to-head MS trial J&J’s ponesimiod tops Aubagio in head-to-head MS trial

    Sets up regulatory filings and possible approval next year. Johnson &Johnson’s oral multiple sclerosis (MS) therapy ponesimod outperformed Sanofi blockbuster Aubagio in a phase 3 comparative trial, setting up regulatory ... Ponesimod, a S1P receptor

  • J&J agrees $30bn deal to acquire Actelion J&J agrees $30bn deal to acquire Actelion

    J&J also takes control of Actelion's late-stage pipeline, including multiple sclerosis candidate ponesimod and cadazolid for diarrhoeal disease, and the US group has also taken an option on

  • J&J back in frame to buy Actelion after Sanofi talks break down J&J back in frame to buy Actelion after Sanofi talks break down

    The two new drugs are predicted to bring in combined sales of $4bn-plus by 2020, and Actelion also has some pipeline candidates in which Clozel has great confidence -including ponesimod

  • Resurgent Actelion catches J&J's eye Resurgent Actelion catches J&J's eye

    J&J could also provide resources to bring forward Actelion's well-regarded pipeline of drugs that extends outside its core focus of PAH, including multiple sclerosis candidate ponesimod and cadazolid

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics